Your browser doesn't support javascript.
loading
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation.
Iavarone, Massimo; Invernizzi, Federica; Czauderna, Carolin; Sanduzzi-Zamparelli, Marco; Bhoori, Sherrie; Amaddeo, Giuliana; Manini, Matteo A; López, Miguel F; Anders, Margarita; Pinter, Matthias; Rodríguez, Maria J B; Cristóbal, Mario R; Soteras, Gabriel A; Piñero, Federico; Villadsen, Gerda E; Weinmann, Arndt; Crespo, Gonzalo; Mazzaferro, Vincenzo; Regnault, Helene; Giorgio, Massimo De; González-Diéguez, Maria L; Donato, Maria F; Varela, Maria; Wörns, Marcus-Alexander; Bruix, Jordi; Lampertico, Pietro; Reig, Maria.
Afiliación
  • Iavarone M; AM& A Migliavacca Center for Liver Disease, Division of Gastroenterology and Hepatology, University of Milan, Fondazione IRCCS Ca' Granda Maggiore Hospital, Milan, Italy.
  • Invernizzi F; AM& A Migliavacca Center for Liver Disease, Division of Gastroenterology and Hepatology, University of Milan, Fondazione IRCCS Ca' Granda Maggiore Hospital, Milan, Italy.
  • Czauderna C; Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany.
  • Sanduzzi-Zamparelli M; Barcelona Clinic Liver Cancer Group, Liver Unit, Hospital Clínic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.
  • Bhoori S; G.I. Surgery and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Amaddeo G; Service d'Hepatologie, Hopital Henri Mondor, Equipe 18, INSERM U955, Virus Immunité Cancer, Créteil, France.
  • Manini MA; Gastroenterology, Hepatology and Transplant Unit, Departement of Specialty and Transplant Medicine Azienda, Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
  • López MF; Liver Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Anders M; Unidad de Hepatología y Trasplante Hepático, Hospital Aleman, Buenos Aires, Argentina.
  • Pinter M; Department of Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Vienna, Austria.
  • Rodríguez MJB; Hospital de Jerez, Jerez de la Frontera, Spain.
  • Cristóbal MR; Liver Department, Gregorio Marañón Hospital, Madrid, Spain.
  • Soteras GA; Sanatorio de la Trinidad Mitre, Buenos Aires, Argentina.
  • Piñero F; Latin American Liver Research Educational and Awareness Network (LALREAN), Hospital Universitario Austral, School of Medicine, Argentina, Buenos Aires, Argentina.
  • Villadsen GE; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus C, Denmark.
  • Weinmann A; Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany.
  • Crespo G; Liver Transplant Unit, Liver Unit, Hospital Clínic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.
  • Mazzaferro V; G. I. Surgery and Liver Trasplantation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy.
  • Regnault H; Service d'Hepatologie, Hopital Henri Mondor, Equipe 18, INSERM U955, Virus Immunité Cancer, Créteil, France.
  • Giorgio M; Gastroenterology, Hepatology and Transplant Unit, Departement of Specialty and Transplant Medicine Azienda, Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
  • González-Diéguez ML; Liver Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Donato MF; AM& A Migliavacca Center for Liver Disease, Division of Gastroenterology and Hepatology, University of Milan, Fondazione IRCCS Ca' Granda Maggiore Hospital, Milan, Italy.
  • Varela M; Liver Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Wörns MA; Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany.
  • Bruix J; Barcelona Clinic Liver Cancer Group, Liver Unit, Hospital Clínic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.
  • Lampertico P; AM& A Migliavacca Center for Liver Disease, Division of Gastroenterology and Hepatology, University of Milan, Fondazione IRCCS Ca' Granda Maggiore Hospital, Milan, Italy.
  • Reig M; Barcelona Clinic Liver Cancer Group, Liver Unit, Hospital Clínic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.
Am J Transplant ; 19(11): 3176-3184, 2019 11.
Article en En | MEDLINE | ID: mdl-31365177
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Hígado / Carcinoma Hepatocelular / Resistencia a Antineoplásicos / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Transplant Año: 2019 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Hígado / Carcinoma Hepatocelular / Resistencia a Antineoplásicos / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Transplant Año: 2019 Tipo del documento: Article País de afiliación: Italia